<DOC>
	<DOCNO>NCT01964638</DOCNO>
	<brief_summary>This prospective single center trial examine rate cancer diagnosis use computerized software target suspicious lesion within prostate identify mpMRI . The primary evaluation involve compare rate cancer diagnosis use software-based MRI-Ultrasound image fusion guide biopsy sample mpMRI finding use visual guide biopsy ( cognitive mental target ) target . The hypothesis test fusion guide biopsy increase detection prostate cancer within mpMRI finding compare visual guide biopsy area</brief_summary>
	<brief_title>Use Multi-Parametric MRI With Prostate Biopsy Cancer Diagnosis .</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>No previous diagnosis adenocarcinoma prostate No contraindication prostate biopsy ( e.g . coagulopathy , medical condition prohibit abstinence antiplatelet anticoagulation therapy , anatomical consideration , anatomical consideration ) Active urinary tract infection Prior pelvic radiotherapy Prior androgen deprivation therapy Evidence urinary tract infection significant urinary retention Prostate instrumentation ( e.g . prostate biopsy , transurethral prostate procedure ) within 2 month prior mpMRI . Contraindication MRI ( severe claustrophobia , indwell metallic object incompatible MRI , pacemaker )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Prostate Biopsy</keyword>
	<keyword>Targeted Biopsy</keyword>
</DOC>